We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

179 hedge funds and large institutions have $1.08B invested in Achillion Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 53 increasing their positions, 58 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

96% more call options, than puts

Call options by funds: $126M | Put options by funds: $64.1M

85% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 26

40% more capital invested

Capital invested by funds: $770M → $1.08B (+$305M)

11% more funds holding

Funds holding: 161 → 179 (+18)

9% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 58

Holders
179
Holders Change
+18
Holders Change %
+11.18%
% of All Funds
4.77%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
48
Increased
53
Reduced
58
Closed
26
Calls
$126M
Puts
$64.1M
Net Calls
+$61.4M
Net Calls Change
-$24.5M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$52.6M
2
DM
Deerfield Management
New York
+$35.7M
3
SAM
Sectoral Asset Management
Quebec, Canada
+$29M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.4M
5
Goldman Sachs
Goldman Sachs
New York
+$20.2M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$32.4M
2
Capital World Investors
Capital World Investors
California
-$30.3M
3
QF
QVT Financial
New York
-$24.3M
4
Renaissance Technologies
Renaissance Technologies
New York
-$8.96M
5
JHIU
Janus Henderson Investors US
Colorado
-$6.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
NI
51
Numeric Investors
Massachusetts
$3.44M +$3.43M +280,900 New
RCAMU
52
Rothschild & Co Asset Management US
Connecticut
$3.29M +$68.1K +5,573 +2%
Charles Schwab
53
Charles Schwab
California
$3.26M +$50.6K +4,142 +2%
Dimensional Fund Advisors
54
Dimensional Fund Advisors
Texas
$3.25M – – –
Connor, Clark & Lunn Investment Management (CC&L)
55
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.17M +$2.26M +185,072 +250%
EI
56
EAM Investors
California
$3.17M +$438K +35,861 +16%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$3.08M +$993K +81,300 +69%
Ameriprise
58
Ameriprise
Minnesota
$2.97M +$1.66M +135,687 +127%
ARTA
59
A.R.T. Advisors
New York
$2.77M -$5.66M -463,272 -67%
BNP Paribas Asset Management
60
BNP Paribas Asset Management
France
$2.58M +$111K +9,100 +5%
First Manhattan
61
First Manhattan
New York
$2.45M – – –
DCM
62
DAFNA Capital Management
California
$2.42M +$2.09M +171,500 +660%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$2.21M +$20.3K +1,664 +0.9%
D.E. Shaw & Co
64
D.E. Shaw & Co
New York
$2.15M +$774K +63,400 +57%
Norges Bank
65
Norges Bank
Norway
$2.08M – – –
AllianceBernstein
66
AllianceBernstein
Tennessee
$2.04M -$305K -25,000 -13%
QI
67
QS Investors
New York
$2.02M +$2.01M +164,895 New
Lord, Abbett & Co
68
Lord, Abbett & Co
New Jersey
$1.96M -$2.2M -179,920 -53%
GH
69
GAM Holding
Switzerland
$1.96M +$1.95M +160,000 New
O
70
OrbiMed
New York
$1.94M – – –
BCM
71
Bridgeway Capital Management
Texas
$1.84M – – –
UBS Group
72
UBS Group
Switzerland
$1.75M +$1.75M +143,077 New
RFC
73
Russell Frank Company
Washington
$1.74M -$227K -18,608 -12%
CS
74
Credit Suisse
Switzerland
$1.7M +$407K +33,298 +32%
SFM
75
Sphera Funds Management
Israel
$1.54M +$1.53M +125,538 New
1 2
3
4 5

ACHN Hedge Fund Activity: Q4 2014 in Review

179 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q4 2014, worth a combined $1.08B — up 40% from $770M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new ACHN positions and 26 closed out — a net gain of 22 holders — while 53 added to existing stakes and 58 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $52.6M. The largest seller was Camber Capital Management, exiting entirely with an estimated $32.4M sold.

  • 179 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q4 2014, up from 161 in Q3 2014.
  • Funds reported $1.08B of Achillion Pharmaceuticals stock for Q4 2014, up 40% quarter-over-quarter.
  • 48 funds opened new Achillion Pharmaceuticals positions in Q4 2014 and 26 closed out, a net change of +22 holders.
  • The largest Achillion Pharmaceuticals buyer in Q4 2014 was Fidelity Investments, an estimated $52.6M added.
  • The largest Achillion Pharmaceuticals seller in Q4 2014 was Camber Capital Management, an estimated $32.4M sold.

Based on aggregated 13F filings for Q4 2014.